← USPTO Patent Applications

BISPECIFIC FUSION PROTEIN TARGETING TNF-a AND IL-17A, AND USE THEREOF

Application US20260077041A1 Kind: A1 Mar 19, 2026

Inventors

Wei XIAO, Zhihang LIU, Liying SONG, Chengkai YIN, Tianyan LIU, Dan YU, Deshan LI, Zhenzhong WANG

Abstract

The present invention relates to a bispecific fusion protein targeting TNF-α and IL-17A, a polynucleotide encoding same, a preparation method therefor, the use thereof, etc. The bispecific fusion protein targeting TNF-α and IL-17A is a dimer which has a bilaterally symmetrical structure, and comprises, in the order from N-terminal to C-terminal, three structural functional regions: a soluble TNF receptor or a portion thereof, a human IgG Fc fragment, and a functional domain competitively binding to IL-17A or against IL-17A. The fusion protein can effectively bind to both TNF-α and IL-17A, and has the effect of blocking the signal pathway thereof. The fusion protein has a good stability, specificity and biological activity.

CPC Classifications

A61K 39/3955 A61K 38/1793 C07K 14/70575 C07K 16/244 C07K 2317/52 C07K 2317/55 C07K 2317/569 C07K 2317/92 C07K 2319/00

Filing Date

2023-12-11

Application No.

19136023